Cargando…
Adult human mesenchymal stromal cells and the treatment of graft versus host disease
Graft versus host disease is a difficult and potentially lethal complication of hematopoietic stem cell transplantation. It occurs with minor human leucocyte antigen (HLA) mismatch and is normally treated with corticosteroid and other immunosuppressive therapy. When it is refractory to steroid thera...
Autores principales: | Herrmann, Richard P, Sturm, Marian J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945047/ https://www.ncbi.nlm.nih.gov/pubmed/24627644 http://dx.doi.org/10.2147/SCCAA.S37506 |
Ejemplares similares
-
Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
por: Kelly, Kilian, et al.
Publicado: (2021) -
Clinical Translation of Mesenchymal Stromal Cell Therapy for Graft Versus Host Disease
por: Godoy, Juliana A. P., et al.
Publicado: (2019) -
Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
por: Dunavin, Neil, et al.
Publicado: (2017) -
Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers
por: Cheung, Tik Shing, et al.
Publicado: (2020) -
Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
por: Kadri, Nadir, et al.
Publicado: (2023)